Transaction · 0001127602-25-006784

Kaye Mark

Kaye Mark, DIR, reported a transaction classified as grant at CONMED Corp involving 152.000000 shares for an estimated $0.00. Reported holdings after the transaction were 152.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
CNMDCONMED Corp
Filing timeFeb 26
Trade dateFeb 24, 2025
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableNot calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

CNMD price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
CNMD since 2025-02-26Filed 588 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001127602-25-006784
RSUs (Restricted Stock Units)
Transaction date
Feb 24, 2025
Filed Feb 26, 2025, 02:33 PM · 2d delay
Shares
152 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
152 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.

  2. F2

    Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms…

Original filing · 0001127602-25-006784
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

CNMD